These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10343158)

  • 61. [The role of CR1 complement receptor in pathology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):84-8. PubMed ID: 20369733
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CR1 deficiency in SLE: acquired or genetic?
    Uko G; Dawkins RL; Kay P; Christiansen FT; Hollingsworth PN
    Clin Exp Immunol; 1985 Nov; 62(2):329-36. PubMed ID: 2935336
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection.
    Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD
    AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene.
    Telen MJ; Eisenbarth GS; Haynes BF
    J Clin Invest; 1983 Jun; 71(6):1878-86. PubMed ID: 6863545
    [TBL] [Abstract][Full Text] [Related]  

  • 65. C3b receptor (CR1) on erythrocytes in various diseases.
    Takemura S; Deguchi M; Ueda M; Yoshida N; Kato H; Yoshikawa T; Sugino S; Kondo M
    Immunol Lett; 1984; 7(6):325-8. PubMed ID: 6233222
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lutheran.
    Daniels G
    Immunohematology; 2009; 25(4):152-9. PubMed ID: 20406022
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune complex clearance by complement receptor type 1 in SLE.
    Kavai M
    Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus.
    Cornillet P; Gredy P; Pennaforte JL; Meyer O; Kazatchkine MD; Cohen JH
    Clin Exp Immunol; 1992 Jul; 89(1):22-5. PubMed ID: 1352746
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative variations of the C3b/C4b receptor (CR1) in human erythrocytes are controlled by genes within the regulator of complement activation (RCA) gene cluster.
    Rodriguez de Cordoba S; Rubinstein P
    J Exp Med; 1986 Oct; 164(4):1274-83. PubMed ID: 2944984
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility.
    Rowe JA; Raza A; Diallo DA; Baby M; Poudiougo B; Coulibaly D; Cockburn IA; Middleton J; Lyke KE; Plowe CV; Doumbo OK; Moulds JM
    Genes Immun; 2002 Dec; 3(8):497-500. PubMed ID: 12486610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Singh V; Mahoney JA; Petri M
    J Rheumatol; 2008 Oct; 35(10):1989-93. PubMed ID: 18709693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.
    Kumar A; Malaviya AN; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Res; 1994; 13(1):61-71. PubMed ID: 7897264
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease.
    de Carvalho Lins CE; Pereira Crott LS; Teixeira JE; Barbosa JE
    Lupus; 2004; 13(7):517-21. PubMed ID: 15352423
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
    Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
    Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of complement receptor type 1-related proteins on primate erythrocytes.
    Nickells MW; Subramanian VB; Clemenza L; Atkinson JP
    J Immunol; 1995 Mar; 154(6):2829-37. PubMed ID: 7876553
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alzheimer's disease is associated with low density of the long CR1 isoform.
    Mahmoudi R; Kisserli A; Novella JL; Donvito B; Dramé M; Réveil B; Duret V; Jolly D; Pham BN; Cohen JH
    Neurobiol Aging; 2015 Apr; 36(4):1766.e5-1766.e12. PubMed ID: 25666996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Near-field quantification of complement receptor 1 (CR1/CD35) protein clustering in human erythrocytes.
    Lapin ZJ; Höppener C; Gelbard HA; Novotny L
    J Neuroimmune Pharmacol; 2012 Sep; 7(3):539-43. PubMed ID: 22374251
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma.
    Jiao XY; Lü MD; Huang JF; Liang LJ; Shi JS
    World J Gastroenterol; 2004 Dec; 10(23):3480-4. PubMed ID: 15526369
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
    Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
    Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.